Skin Cancers Terminated Phase 4 Trials for Sirolimus (DB00877)

Also known as: Cancer of Skin / Skin Cancer / [X]Malignant neoplasm of skin, unspecified / Skin malignant neoplasm NOS / Malignant skin neoplasm NOS / Skin neoplasms malignant and unspecified / Skin neoplasm malignant NOS / Skin neoplasm malignant

IndicationStatusPhase
DBCOND0046599 (Skin Cancers)Terminated4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00866684Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive ProtocolPrevention